Effects of Corticosteroid Use on Restoration of Spontaneous Circulation in Cardiac Arrest Patients
Launched by SAGLIK BILIMLERI UNIVERSITESI · Jul 17, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how the use of corticosteroids (a type of medication that can reduce inflammation) before a cardiac arrest affects the ability to restore normal heart function after the event. The researchers want to see if patients who had taken corticosteroids before experiencing a cardiac arrest—whether in a hospital or outside of one—will have a different recovery experience compared to those who did not. They will also look at how these medications influence the need for other drugs used to support heart function after the heart starts beating again.
To participate in this trial, individuals must be at least 18 years old and have experienced a witnessed cardiac arrest. However, those with certain conditions, such as traumatic cardiac arrest or those whose heart did not start beating again after resuscitation efforts lasting over 20 minutes, will not be eligible. The trial is currently not recruiting participants, so no one can join just yet. If you or a loved one meet the eligibility criteria in the future, you may have the opportunity to contribute to important research that could improve care for cardiac arrest patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 and above Witnessed cardiac arrest
- Exclusion Criteria:
- • Traumatic cardiac arrest Forensic cases Cardiac arrest secondary to ST-elevation myocardial infarction Patients in whom spontaneous circulation could not be achieved despite cardiopulmonary resuscitation lasting more than 20 minutes Patients with inaccessible past medical records or unknown medication history Patients without identification Unwitnessed cardiac arrest Pregnant patients
About Saglik Bilimleri Universitesi
Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Trial Officials
gulsen akcay, ass. prof.
Study Director
ass. prof. of organization
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported